France· FR:62862068
AGILUS 120 mg, poudre pour solution injectable
A medicinal product, registered in France by NORGINE (PAYS-BAS).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Manufacturer
- NORGINE (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009551016426 flacons en verre
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
AGILUS in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAgilus 120 mg poeder voor oplossing voor injectieNorgine B.V.
- United KingdomAgilus 120mg powder for solution for injection vialsForum Health Products Ltd
- United StatesDantriumPar Health USA, LLC
- SwitzerlandAgilus 120 mg, Pulver zur Herstellung einer InjektionslösungNorgine AG
- IrelandAgilus 120 mg powder for solution for injectionNorgine B.V.
- CanadaDANTRIUM CAPSULESENDO OPERATIONS LTD.
- FinlandAgilusOrifarm Oy
- CzechiaAGILUSNorgine B.V., Amsterdam
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Belgium · Dantrium Iv
- Germany · Dantamacrin, Dantrolen I.V.
- United Kingdom (Northern Ireland) · Agilus, dantrium
- Ireland · Dantrium
- Iceland · Agilus
- Italy · Dantrium
- Liechtenstein · Agilus
- Netherlands · Dantrium
- Norway · Agilus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a8dc32ec-9c3a-4d39-b14c-792937efc152 GET /v1/drugs/a8dc32ec-9c3a-4d39-b14c-792937efc152?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62862068",
"date_amm": "2024-05-29",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/24/1805",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about AGILUS.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.